FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135202408> ?p ?o ?g. }

• W3135202408 abstract "Abstract To investigate the potential benefits of acarbose therapy on cardiovascular events (CVD) in Type 2 diabetes (T2DM) in an urban community over 10-year follow-up. The study population of Beijing Community Diabetes Study (BCDS) were type 2 diabetes (T2DM) living in 21 communities in Beijing. All patients received comprehensive intervention in accordance with the Chinese guidelines for the prevention and treatment of diabetes. Professors in endocrinology from top tier hospitals regularly visited the communities for consultations, which was a feature of this study. A total of 1797 T2DM in BCDS study had complete screening data, including blood glucose, blood pressure, lipid profiles and acarbose continuous therapy. After 10-year follow-up, the risks of CVD outcomes were assessed according to whether patients had received acarbose therapy or not. All patients were followed-up to assess the long-term effects of the multifactorial interventions. At baseline, compared with the acarbose therapy free in T2DM, there was no significant difference in achieving the joint target control in patients with acarbose therapy. From the beginning of 8th year follow-up, the joint target control rate in patients with acarbose therapy was significantly higher than that of acarbose therapy free. During the 10-year follow-up, a total of 446 endpoint events occurred, including all-cause death, cardiovascular events, cerebrovascular events. The incidences of myocardial infarction (from the 4th year of follow-up) and all-cause death (from the 2nd year of follow-up) in patients who received acarbose therapy were significantly lower than that of acarbose therapy free respectively. In Cox multivariate analyses, there were significant differences in incidences of myocardial infarction and all-cause death between afore two groups during the 10-year follow-up, and the adjusted HRs were 0.50 and 0.52, respectively. After multifactorial interventions, T2DM with acarbose therapy revealed significant reductions of myocardial infarction and all-cause death. The long-term effects of with acarbose therapy on improving joint target control might be one of the main reasons of myocardial infarction and all-cause death reduction. Trial Registration : ChiCTR-TRC-13003978, ChiCTR-OOC-15006090." @default.
• W3135202408 created "2021-03-15" @default.
• W3135202408 creator A5004318102 @default.
• W3135202408 creator A5030509416 @default.
• W3135202408 creator A5037377751 @default.
• W3135202408 creator A5039663131 @default.
• W3135202408 creator A5043567752 @default.
• W3135202408 creator A5052876946 @default.
• W3135202408 creator A5054588537 @default.
• W3135202408 creator A5054764310 @default.
• W3135202408 creator A5058079930 @default.
• W3135202408 creator A5075183274 @default.
• W3135202408 creator A5080003955 @default.
• W3135202408 creator A5084120665 @default.
• W3135202408 creator A5088869525 @default.
• W3135202408 creator A5091541757 @default.
• W3135202408 date "2021-03-01" @default.
• W3135202408 modified "2023-09-25" @default.
• W3135202408 title "The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24)" @default.
• W3135202408 cites W1593109535 @default.
• W3135202408 cites W1986699928 @default.
• W3135202408 cites W1994296114 @default.
• W3135202408 cites W2000689577 @default.
• W3135202408 cites W2006165608 @default.
• W3135202408 cites W2016052123 @default.
• W3135202408 cites W2019381594 @default.
• W3135202408 cites W2021119815 @default.
• W3135202408 cites W2026314563 @default.
• W3135202408 cites W2029749250 @default.
• W3135202408 cites W2039993581 @default.
• W3135202408 cites W2073068020 @default.
• W3135202408 cites W2130668899 @default.
• W3135202408 cites W2171294019 @default.
• W3135202408 cites W2544567996 @default.
• W3135202408 cites W2731349674 @default.
• W3135202408 cites W2790368008 @default.
• W3135202408 cites W2897457722 @default.
• W3135202408 cites W2927309956 @default.
• W3135202408 cites W2948261890 @default.
• W3135202408 cites W2988695676 @default.
• W3135202408 cites W3014148348 @default.
• W3135202408 cites W3084354032 @default.
• W3135202408 doi "https://doi.org/10.1038/s41598-021-84015-0" @default.
• W3135202408 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8138014" @default.
• W3135202408 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34017044" @default.
• W3135202408 hasPublicationYear "2021" @default.
• W3135202408 type Work @default.
• W3135202408 sameAs 3135202408 @default.
• W3135202408 citedByCount "4" @default.
• W3135202408 countsByYear W31352024082022 @default.
• W3135202408 countsByYear W31352024082023 @default.
• W3135202408 crossrefType "journal-article" @default.
• W3135202408 hasAuthorship W3135202408A5004318102 @default.
• W3135202408 hasAuthorship W3135202408A5030509416 @default.
• W3135202408 hasAuthorship W3135202408A5037377751 @default.
• W3135202408 hasAuthorship W3135202408A5039663131 @default.
• W3135202408 hasAuthorship W3135202408A5043567752 @default.
• W3135202408 hasAuthorship W3135202408A5052876946 @default.
• W3135202408 hasAuthorship W3135202408A5054588537 @default.
• W3135202408 hasAuthorship W3135202408A5054764310 @default.
• W3135202408 hasAuthorship W3135202408A5058079930 @default.
• W3135202408 hasAuthorship W3135202408A5075183274 @default.
• W3135202408 hasAuthorship W3135202408A5080003955 @default.
• W3135202408 hasAuthorship W3135202408A5084120665 @default.
• W3135202408 hasAuthorship W3135202408A5088869525 @default.
• W3135202408 hasAuthorship W3135202408A5091541757 @default.
• W3135202408 hasBestOaLocation W31352024081 @default.
• W3135202408 hasConcept C126322002 @default.
• W3135202408 hasConcept C134018914 @default.
• W3135202408 hasConcept C2776617576 @default.
• W3135202408 hasConcept C2777180221 @default.
• W3135202408 hasConcept C2908647359 @default.
• W3135202408 hasConcept C2910068830 @default.
• W3135202408 hasConcept C500558357 @default.
• W3135202408 hasConcept C555293320 @default.
• W3135202408 hasConcept C71924100 @default.
• W3135202408 hasConcept C99454951 @default.
• W3135202408 hasConceptScore W3135202408C126322002 @default.
• W3135202408 hasConceptScore W3135202408C134018914 @default.
• W3135202408 hasConceptScore W3135202408C2776617576 @default.
• W3135202408 hasConceptScore W3135202408C2777180221 @default.
• W3135202408 hasConceptScore W3135202408C2908647359 @default.
• W3135202408 hasConceptScore W3135202408C2910068830 @default.
• W3135202408 hasConceptScore W3135202408C500558357 @default.
• W3135202408 hasConceptScore W3135202408C555293320 @default.
• W3135202408 hasConceptScore W3135202408C71924100 @default.
• W3135202408 hasConceptScore W3135202408C99454951 @default.
• W3135202408 hasFunder F4320325902 @default.
• W3135202408 hasIssue "1" @default.
• W3135202408 hasLocation W31352024081 @default.
• W3135202408 hasLocation W31352024082 @default.
• W3135202408 hasLocation W31352024083 @default.
• W3135202408 hasOpenAccess W3135202408 @default.
• W3135202408 hasPrimaryLocation W31352024081 @default.
• W3135202408 hasRelatedWork W1563850031 @default.
• W3135202408 hasRelatedWork W2032987462 @default.
• W3135202408 hasRelatedWork W2079623117 @default.
• W3135202408 hasRelatedWork W2316107365 @default.
• W3135202408 hasRelatedWork W2367140913 @default.
• W3135202408 hasRelatedWork W2377483921 @default.

• next